Our Commitment

Millions of Americans live with serious diseases. At Janssen Biotech, Inc. we dedicate our hearts and minds to improving the health of these individuals in three distinct areas where the burden is great:

• Immunology

  Approximately 10 million people in the United States live with immunologic disorders, such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis and plaque psoriasis. Our goal is to improve health through therapies that treat immunologic disorders, and provide patient support programs that address the multiple aspects of living with these diseases.

• Oncology

  Cancer is the second most common cause of death in the U.S. Men have slightly less than a 1 in 2 lifetime risk of developing cancer; for women, the risk is a little more than 1 in 3. Cancer is a significant heath problem in the U.S and throughout the world. Our goal in oncology is to aid health professionals in the treatment of these serious diseases, by providing safe and effective therapeutic options to help improve patient health.

• Nephrology

  Approximately 28 million Americans have evidence of chronic kidney disease, and 28 million more are at risk. Janssen Biotech, Inc. is committed to providing therapeutic and supportive care solutions for the nephrology community.

In each of our therapeutic areas, we are at the forefront of developing education and public policy initiatives to ensure that patients and their families, caregivers, advocates and healthcare professionals have access to the latest treatment information, support services and quality care. We believe that changing lives for the better takes more than medicine.